In cooperation with the partner company Bruker Daltonik GmbH, the innovation partnership M²Aind organized the second congress "Bruker's and M²Aind's VIP Day 2019" at the Mannheim University of Applied Sciences at the beginning of the summer semester 2019. Over two days, around 120 industry and university representatives from the fields of pharmaceuticals, diagnostics, chemistry, medical technology and biotechnology used the opportunity to network and exchange information on the latest research findings.
The event focused on new label-free technologies for pharmaceutical research and development: pharmaceutical applications from MALDI MS Imaging and MALDI PharmaPulse for high-throughput screening using MALDI mass spectrometry, surface plasmon resonance for compound profiling and NMR spectroscopy for fragment-based screening. The audience was very interested in various current application areas, which were presented by the speakers in about 20 lectures.
The speakers came from researching companies and scientific institutions such as : Bayer (Germany), Boehringer Ingelheim (Germany), Bruker (Germany), ETH Zurich (Switzerland), Evosep (Denmark), CeMOS (Germany), Harvard Medical School (USA), GlaxoSmithKline (UK), Merck (Germany), Newcastle University (UK), Osaka University (Japan), Roche (Switzerland), Servier (France).
Prof. Dr. Carsten Hopf, initiator of the event and head of the CeMOS - Center for Mass Spectrometry and Optical Spectroscopy research center at Mannheim University of Applied Sciences, invited interested parties to a tour of the BMBF- and DFG-funded Rhein-Neckar Center for MS Imaging and MS Assays.
"An international congress for MALDI mass spectrometry tailored to the fields of interest of the pharmaceutical industry - label-free assay technologies on the one hand and mass spectrometric imaging for DMPK and toxicology on the other - has never before been held in Germany. The great response documents the need for these technologies, and I am glad that Bruker has organized such an event with M²Aind", Prof. Hopf looked back on a successful congress with international lectures.
The prorector for research and technology transfer at Mannheim University of Applied Sciences, Prof. Dr. Mathias Hafner, assessed the event as a complete success for the M²Aind innovation partnership: "The great interest of the industry in this event confirms that we have set the right priorities in research; we are internationally competitive at the highest level".